Viking TherapeuticsVKTX
About: Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Employees: 30
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
104% more call options, than puts
Call options by funds: $321M | Put options by funds: $157M
60% more repeat investments, than reductions
Existing positions increased: 162 | Existing positions reduced: 101
24% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 75
5% more funds holding
Funds holding: 366 [Q1] → 384 (+18) [Q2]
1.08% less ownership
Funds ownership: 73.93% [Q1] → 72.85% (-1.08%) [Q2]
36% less capital invested
Capital invested by funds: $6.63B [Q1] → $4.26B (-$2.37B) [Q2]
54% less funds holding in top 10
Funds holding in top 10: 13 [Q1] → 6 (-7) [Q2]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
HC Wainwright & Co. Joseph Pantginis 35% 1-year accuracy 90 / 255 met price target | 37%upside $90 | Buy Reiterated | 9 Oct 2024 |
Oppenheimer Jay Olson 29% 1-year accuracy 14 / 48 met price target | 110%upside $138 | Outperform Reiterated | 25 Sept 2024 |
Morgan Stanley Michael Ulz 41% 1-year accuracy 7 / 17 met price target | 59%upside $105 | Overweight Reiterated | 12 Sept 2024 |
JP Morgan Hardik Parikh 50% 1-year accuracy 2 / 4 met price target | 22%upside $80 | Overweight Initiated | 11 Sept 2024 |
Raymond James Steven Seedhouse 50% 1-year accuracy 11 / 22 met price target | 79%upside $118 | Strong Buy Maintained | 25 Jul 2024 |
Financial journalist opinion
Based on 25 articles about VKTX published over the past 30 days